MTX group (n = 120) | Curettage group (n = 106) | Hysteroscopy group (n = 221) | P value | |
---|---|---|---|---|
Treatment success | 103 (85.8%) | 89 (84.0%) | 212 (95.9%) | < 0.001 |
Surgery time (min) | 20.0 (10.0 30.0) | 20.0 (15.0 30.0) | 25.0 (20.0 30.0) | 0.001 |
Blood loss (ml) | 20.0(10.0, 50.0) | 20.0 (10.0 20.0) | 20.0 (10.0 30.0) | 0.455 |
Blood transfusion Yes | 1 (0.8%) | 3 (2.8%) | 4 (1.8%) | 0.513 |
No | 119 (99.2%) | 103 (97.2%) | 217 (98.2%) | |
β-hCG after treatment (mIU/ml) | 1462.5 (307.443757.57) | 4611.00 (1125.009713.00) | 5108.00 (2213.509978.50) | < 0.001 |
β-hCG difference (mIU/ml) | 17,562.10 (2945.7046044.62) | 19,640.00 (9506.0054520.85) | 17,305.00 (5929.1534914.25) | 0.629 |
Rate of β-hCG decline (%) | 91.73 (84.45 96.38) | 86.46 (74.26 92.43) | 78.07 (68.37 85.14) | < 0.001 |
Hospital time (days) | 9.0 (7.0, 16.0) | 3.0 (2.0 5.0) | 4.0 (3.0 5.0) | < 0.001 |
Hospitalization expenses (¥) | 13,677.50 (8240.75, 16,760.75) | 4005.70 (3390.075632.22) | 11,640.68 (10,746.3312684.02) | < 0.001 |